Concepedia

Ian Dainty

ID

15

Publications

642

Citations

12

H-Index

1988

Active since

Affiliations

Loughborough University(Current)

AstraZeneca (Sweden)

AstraZeneca (United Kingdom)

Czech Academy of Sciences, Institute of Physiology

University of Glasgow

Ian Dainty is an author at Loughborough University specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

1988–2023

15

Publications

15

Cloning and Characterization of a Bovine P2Y Receptor ∮

Duncan J. Henderson, Dean Elliot, G M Smith et al. · Biochemical and Biophysical Research Communications · 1995 · 113 citations

, , +6

P2Y<sub>1</sub>‐receptors in human platelets which are pharmacologically distinct from P2Y<sub>ADP</sub>‐receptors

Malbinder Fagura, Ian Dainty, G D McKay et al. · British Journal of Pharmacology · 1998 · 100 citations · Full text

Pharmacological Characterization of AZD5069, a Slowly Reversible CXC Chemokine Receptor 2 Antagonist

David Nicholls, Katherine Wiley, Ian Dainty et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 89 citations

The influence of the initial stretch and the agonist‐induced tone on the effect of basal and stimulated release of EDRF

Ian Dainty, J.C. McGrath, Michael Spedding et al. · British Journal of Pharmacology · 1990 · 57 citations · Full text

P2Y purinoceptor and nucleotide receptor-induced relaxation of precontracted bovine aortic collateral artery rings: differential sensitivity to suramin and indomethacin.

Graeme Wilkinson, K. McKechnie, Ian Dainty et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 55 citations

Rows per page

1–5 of 15